Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | -4,657 | 11,211 | 5,447 | 3,176 | 0 |
| Operating Income | 4,657 | -11,211 | -5,447 | -3,176 | 0 |
| Interest Expense | 3,140 | 146 | 283 | 115 | 0 |
| Other Income | 201 | -58 | 128 | 1 | 0 |
| Pre-tax Income | 1,718 | -11,415 | -5,602 | -3,290 | 0 |
| Net Income Continuous | 1,718 | -11,415 | -5,602 | -3,290 | 0 |
| Net Income | $1,718 | $-11,415 | $-5,602 | $-3,290 | $0 |
| EPS Basic Total Ops | 317.59 | -12.87 | -218.18 | -133.84 | N/A |
| EPS Basic Continuous Ops | 317.49 | -12.84 | -218.13 | -133.83 | N/A |
| EPS Diluted Total Ops | 317.59 | -12.87 | -218.18 | -133.84 | N/A |
| EPS Diluted Continuous Ops | 317.49 | -12.84 | -218.13 | -133.83 | N/A |
| EBITDA(a) | $6,499 | $-11,120 | $-5,339 | $-3,122 | $0 |